BioHarvest Sciences Inc. (BHST)
NASDAQ: BHST · Real-Time Price · USD
6.95
+0.12 (1.76%)
Nov 26, 2025, 11:11 AM EST - Market open
BioHarvest Sciences Revenue
BioHarvest Sciences had revenue of $9.07M in the quarter ending September 30, 2025, with 38.66% growth. This brings the company's revenue in the last twelve months to $32.72M, up 45.88% year-over-year. In the year 2024, BioHarvest Sciences had annual revenue of $25.19M with 98.77% growth.
Revenue (ttm)
$32.72M
Revenue Growth
+45.88%
P/S Ratio
3.63
Revenue / Employee
$16,360,000
Employees
2
Market Cap
157.45M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.19M | 12.52M | 98.77% |
| Dec 31, 2023 | 12.67M | 7.17M | 130.48% |
| Dec 31, 2022 | 5.50M | 3.40M | 161.56% |
| Dec 31, 2021 | 2.10M | 1.71M | 430.81% |
| Dec 31, 2020 | 396.00K | 178.00K | 81.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Walmart | 703.06B |
| Costco Wholesale | 275.24B |
| PepsiCo | 92.37B |
| The Procter & Gamble Company | 84.93B |
| Unilever | 70.19B |
| Anheuser-Busch InBev | 58.61B |
| The Coca-Cola Company | 47.66B |
| Philip Morris International | 39.99B |
BHST News
- 12 days ago - BioHarvest Sciences Inc. (BHST) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - BioHarvest Sciences Reports Third Quarter 2025 Financial Results - Newsfile Corp
- 14 days ago - BioHarvest Sciences to Attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025 - Newsfile Corp
- 15 days ago - BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter's Option to Purchase Additional Shares - Newsfile Corp
- 19 days ago - BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock - Newsfile Corp
- 19 days ago - BioHarvest Announces Proposed Public Offering of Common Stock - Newsfile Corp
- 22 days ago - BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time - Newsfile Corp
- 27 days ago - BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis - Newsfile Corp